CIK 0000842023
- Large accelerated filer
BIO-TECHNE Corp
Sign in to watch- Ticker
- TECH
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Jun 30
- Incorporated
- MN
- Entity type
- Operating
- EIN
- 411427402
- Phone
- +1 612-379-8854
- Business address
- 614 MCKINLEY PLACE NE, MINNEAPOLIS, MN
- Former names
- TECHNE CORP /MN/
- 4 Open-market sale Director sold 4,000 shares at an average $485.55 ($1,942,183)
- 4 Open-market sale SVP - General Counsel sold 3,538 shares at an average $473.95 ($1,676,849)
- 4 Option exercise Chief Executive Officer acquired 921 shares (option exercise)
- 4 Shares withheld for taxes Chief Executive Officer gave up 12,475 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $478.90 ($4,788,992)
- 4 Shares withheld for taxes Pres. Diagnostics & Genom gave up 869 shares (to pay taxes)
- 4 Shares withheld for taxes SVP - General Counsel gave up 677 shares (to pay taxes)
- 4 Shares withheld for taxes President-Protein Sciences gave up 999 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $456.67 ($4,566,663)
- 4 Open-market sale Chief Executive Officer sold 12,498 shares at an average $449.67 ($5,620,006)
- 4 Open-market sale Chief Executive Officer sold 7,481 shares at an average $449.15 ($3,360,066)
- 4 Open-market sale Pres. Diagnostics & Genom sold 811 shares at $433.00 ($351,163)
- 4 Open-market sale Chief Financial Officer sold 9,942 shares at an average $421.93 ($4,194,831)
- 4 Open-market sale Pres. Diagnostics & Genom sold 845 shares at $424.00 ($358,280)
- 4 Shares withheld for taxes Chief Executive Officer gave up 21,305 shares (to pay taxes)
- 4 Shares withheld for taxes Pres. Diagnostics & Genom gave up 856 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 17,428 shares (to pay taxes)
- 4 Open-market sale Chief Financial Officer sold 10,000 shares at an average $400.39 ($4,003,908)
- 4 Open-market sale SVP - General Counsel sold 10,000 shares at an average $398.64 ($3,986,352)
Page 11 of 35 · 695 filings